In a move with potentially significant implications for employers' approaches to drug testing, reasonable accommodation under the ADA and other workplace policies, the Department of Justice recently issued an order that reclassifies certain medical marijuana products as Schedule III controlled substances.
Nebraska employers may need to revise workplace drug policies following voter approval of a ballot initiative decriminalizing the use of medical marijuana.